Statistics for A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium

Total visits

views
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium 0

Total visits per month

views
May 2024 0
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0